1. Home
  2. ASLE vs ITRM Comparison

ASLE vs ITRM Comparison

Compare ASLE & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AerSale Corporation

ASLE

AerSale Corporation

HOLD

Current Price

$6.49

Market Cap

299.0M

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

SELL

Current Price

$0.03

Market Cap

24.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ASLE
ITRM
Founded
2008
2015
Country
United States
Ireland
Employees
704
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
299.0M
24.3M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
ASLE
ITRM
Price
$6.49
$0.03
Analyst Decision
Hold
Buy
Analyst Count
2
2
Target Price
$7.00
$9.00
AVG Volume (30 Days)
263.8K
29.3M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
63.64
57.43
EPS
0.18
N/A
Revenue
$335,286,000.00
N/A
Revenue This Year
$23.41
N/A
Revenue Next Year
$6.80
$947.65
P/E Ratio
$35.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.56
$0.03
52 Week High
$9.08
$1.42

Technical Indicators

Market Signals
Indicator
ASLE
ITRM
Relative Strength Index (RSI) 49.17 26.10
Support Level $5.67 N/A
Resistance Level $6.56 $0.39
Average True Range (ATR) 0.16 0.02
MACD 0.06 -0.01
Stochastic Oscillator 74.15 3.34

Price Performance

Historical Comparison
ASLE
ITRM

About ASLE AerSale Corporation

AerSale Corp offers full-service support to owners and operators of mid-life commercial aircraft. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing various maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. AerSale also offers asset management services to owners of end-of-life aircraft and engine portfolios. The company has two reportable segments: Asset Management Solutions and TechOps. Maximum revenue is generated from the Asset Management Solutions segment, which comprises activities to extract value from strategic asset acquisitions through leasing, trading, or disassembling for product sales. Geographically, the company derives maximum revenue from its domestic market.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: